Christopher Benoit

Christopher Benoit is an experienced executive in the biotechnology sector, currently serving as an Executive Advisor at Canal Biosciences since February 2024 and as EVP, Advisor at Maravai LifeSciences. Benoit is the owner of Benoit Capital Partners LLC, which has been operational since August 2016. Previously, Benoit held the positions of Chief Executive Officer at Alphazyme LLC and TwinStrand Biosciences, where efforts focused on advancing innovative sequencing technologies. Benoit's extensive background includes leadership roles at Enzymatics, spanning from Chief Commercial Officer to VP, Head of Reagents, and product management at New England Biolabs. Benoit holds a Bachelor of Science degree in Biochemistry from the University of Massachusetts Amherst.